Lite Strategy, Inc. (LITS)
NASDAQ: LITS · Real-Time Price · USD
1.090
-0.005 (-0.46%)
At close: May 19, 2026, 4:00 PM EDT
1.100
+0.010 (0.92%)
After-hours: May 19, 2026, 5:37 PM EDT
Lite Strategy Employees
Lite Strategy had 4 employees as of June 30, 2025. The number of employees decreased by 24 or -85.71% compared to the previous year.
Employees
4
Change (1Y)
-24
Growth (1Y)
-85.71%
Revenue / Employee
n/a
Profits / Employee
-$15,205,000
Market Cap
39.63M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 4 | -24 | -85.71% |
| Jun 30, 2024 | 28 | -18 | -39.13% |
| Jun 30, 2023 | 46 | -56 | -54.90% |
| Jun 30, 2022 | 102 | 26 | 34.21% |
| Jun 30, 2021 | 76 | 25 | 49.02% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Mereo BioPharma Group | 39 |
| Plus Therapeutics | 28 |
| Actinium Pharmaceuticals | 25 |
| INmune Bio | 21 |
| Tevogen Bio Holdings | 18 |
| Quantum BioPharma | 17 |
| RenovoRx | 17 |
| Atossa Therapeutics | 16 |
LITS News
- 6 days ago - Lite Strategy Reports Fiscal 2026 Third Quarter Results - GlobeNewsWire
- 6 days ago - Lite Strategy Quarterly report: Q3 2026 - Filings
- 6 days ago - Lite Strategy Earnings release: Q3 2026 - Filings
- 3 months ago - Lite Strategy reports Q2 EPS (82c) vs. (40c) last year - TheFly
- 3 months ago - Lite Strategy to continue to evaluate strategic investments in 2H of 2026 - TheFly
- 3 months ago - Lite Strategy Reports Fiscal 2026 Second Quarter Results - GlobeNewsWire
- 3 months ago - Lite Strategy Earnings release: Q2 2026 - Filings
- 3 months ago - Lite Strategy Quarterly report: Q2 2026 - Filings